Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Colorectal Cancers”

3,048 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,048 results

Early research (Phase 1)Looking for participantsNCT05176483
What this trial is testing

Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors

Who this might be right for
Renal Cell Carcinoma (RCC)Metastatic Castration-Resistant Prostate Cancer (mCRPC)Urothelial Carcinoma (UC)+7 more
Exelixis 1,314
Not applicableStudy completedNCT06856590
What this trial is testing

ZINCLO-HAND: Zinc and Clobetasol for the Prevention of Regorafenib-Induced Hand-Foot Skin Reaction

Who this might be right for
Hand-Foot Skin Reaction (HFSR)
Gazi University 150
Not applicableLooking for participantsNCT04854213
What this trial is testing

PRELUDE-1 (Prospective Evaluation of Radiotherapy-induced Biologic Effects in Colorectal Cancer Oligometastatic Patients with LUng-limited Disease: Evolution of Cancer Genetics and Regulatory Immune Cells)

Who this might be right for
Colorectal Cancer Metastatic
National Cancer Institute, Naples 25
Not applicableUnknownNCT03175146
What this trial is testing

See Whether Stereotactic Body RadioTherapy (SBRT) Can Shrink Tumours Within the Liver Safely

Who this might be right for
Colonic NeoplasmsNeoplasm Metastasis
AHS Cancer Control Alberta 30
Testing effectiveness (Phase 2)Study completedNCT00002842
What this trial is testing

Liver Resection and Floxuridine Plus Fluorouracil and Leucovorin in Treating Patients With Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
City of Hope Medical Center 49
Testing effectiveness (Phase 2)Study completedNCT00514761
What this trial is testing

Phase II Efficacy Study of AZD6244 in Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
AstraZeneca 64
Large-scale testing (Phase 3)Ended earlyNCT05223673
What this trial is testing

Phase 3 Study of Futuximab/Modotuximab in Combination With Trifluridine/Tipiracil Versus Trifluridine/Tipiracil Single Agent in Participants With Previously Treated Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Institut de Recherches Internationales Servier 7
Testing effectiveness (Phase 2)Ended earlyNCT01060423
What this trial is testing

TACE With Irinotecan Drug-eluting Beads and Intravenous (IV) Cetuximab in Refractory Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hans-Joachim Schmoll, MD 8
Testing effectiveness (Phase 2)Study completedNCT01386242
What this trial is testing

Recombinant Anti-tumor and Anti-virus Protein for Injection in Treatment of Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 108
Testing effectiveness (Phase 2)WithdrawnNCT02575508
What this trial is testing

Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer

Who this might be right for
Colon AdenocarcinomaMetastatic Pancreatic AdenocarcinomaPancreatic Adenocarcinoma+14 more
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00345696
What this trial is testing

1stline Study Capecitabine Administered on Continuous Way Plus Oxaliplatin&Bevacizumab Every 2weeks in Metastatic CCR.

Who this might be right for
Metastatic Colorectal Cancer
Unidad Integral de Investigación en Oncología S.L. 32
Testing effectiveness (Phase 2)WithdrawnNCT02965417
What this trial is testing

Sym004 in Metastatic Colorectal Cancer and ECD-EGFR Patients

Who this might be right for
Metastatic Colorectal Cancer
Symphogen A/S
Not applicableWithdrawnNCT04274790
What this trial is testing

Impact of 5-Fluorouracil (5-FU) on Cancer Cells From Liver Metastases of Colon Cancer

Who this might be right for
Cancer of ColonMetastasis to Liver
Centre Leon Berard
Testing effectiveness (Phase 2)Ended earlyNCT00959946
What this trial is testing

Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer

Who this might be right for
Advanced Breast Cancer (Parts 1 and 2)Advanced Pancreatic Cancer (Part 1)Advanced Colorectal Cancer (Part 1)+2 more
Pfizer 32
Not applicableStudy completedNCT00724503
What this trial is testing

FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer

Who this might be right for
Colorectal CancerColorectal CarcinomaLiver Metastases
Sirtex Medical 530
Not applicableStudy completedNCT02942901
What this trial is testing

Clinical Evaluation of PET-CT for Staging of Colorectal Lung Metastases

Who this might be right for
Metastatic Colorectal Cancer
Lung Clinic Heckeshorn 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT04699188
What this trial is testing

Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation

Who this might be right for
KRAS G12C Mutant Solid TumorsCarcinoma, Non-Small-Cell LungCarcinoma, Colorectal+7 more
Novartis Pharmaceuticals 344
Early research (Phase 1)Ended earlyNCT02110953
What this trial is testing

Irinotecan-Eluting Beads in Treating Patients With Refractory Metastatic Colon or Rectal Cancer That Has Spread to the Liver

Who this might be right for
Liver MetastasesMucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the Rectum+8 more
Fox Chase Cancer Center 2
Testing effectiveness (Phase 2)Study completedNCT01802320
What this trial is testing

Akt Inhibitor MK2206 in Treating Patients With Previously Treated Colon or Rectal Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery

Who this might be right for
Colon Mucinous AdenocarcinomaColon Signet Ring Cell AdenocarcinomaRectal Mucinous Adenocarcinoma+13 more
National Cancer Institute (NCI) 18
Not applicableActive Not RecruitingNCT03451370
What this trial is testing

First-line Combination of Capecitabine and Oxaliplatin Plus Bevacizumab in Elderly Patients With Metastatic Colorectal Cancer

Who this might be right for
Elderly Metastatic Colorectal Cancer Patients
Istituto Oncologico Veneto IRCCS 121
Load More Results